Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

Dr Reddy's, Zydus Lifesciences,... Feb 19, 2025 19:23 Cipla Q3 Profit Surges 49% to Rs 1,571 Crore Cipla's net profit for Q3 FY25 jumped 49% to Rs 1,571 crore, driven by growth across markets. Revenue ...

Drug major Cipla reported a 49% year-on-year jump in its December quarter consolidated net profit, reaching Rs 1,571 crore, compared to Rs 1,056 crore in the same period last year. The profit after ...

After hours: February 20 at 6:40:00 PM EST ...

The Ebitda margin expanded to 28.1% from 26.5%. Cipla also posted an exceptional loss of Rs 195 crore in the third quarter. Revenue rises 7.1% to Rs 7,073 crore versus Rs 6,604 crore (Bloomberg ...

>> Momentum Oscillators like RSI and MFI are in rising mode and placed above 50 on the daily chart, indicating strength in the current uptrend.

Cipla has been helping extend the reach of affordable life-saving HIV/AIDS medications since 2001. The company supplies antiretroviral (ARV) medicines to 64 countries by mostly participating in the ...

Shares of drugmaker Cipla Ltd. surged to the day's high, gaining as much as 4% after the company's December quarter results. The results were a beat across parameters.

Return on investment - most recent fiscal year 16.16 ...

HYDERABAD/BENGALURU (Reuters) - Cipla, one of India's largest drugmakers ... as per LSEG data. ($1 = 86.5325 Indian rupees) (This story has been corrected to remove the reference to strong demand ...

Its diclofenac sodium ... at 1 week that was sustained through 12 weeks of treatment. Overall, Voltaren Arthritis Pain Gel is a great option for those looking for a powerful topical arthritis ...